Deepak Fertilizers and Petrochemicals Corporation Limited (DEEPAKFERT) Q2 FY27 Financial Results: PAT ₹490 Cr & Revenue ₹3,256 Cr (3 announcements)

Deepak Fertilizers reported Q1 FY27 net profit of ₹6834 lakhs ([amount not verified]), up 101% YoY and 252% QoQ, driven by strong revenue growth to [amount not verified] (+22% YoY, +8% QoQ) and improved margins. The company reappointed P G Bhagwat LLP as tax auditor for FY27, with a limited review report covering Q1 results. Revenue growth was fueled by specialty chemicals (43% contribution) and favorable pricing in mining chemicals, while crop nutrition faced headwinds from monsoon delays and input cost pressures. Major projects at Dahej and Gopalpur neared completion, targeting enhanced market leadership. Management reaffirmed strategic focus on premiumization and value-based pricing amid elevated industry conditions.

Deepak Fertilizers reported Q1 FY27 revenue of ₹3,256 crores, up 22% YoY and 8% QoQ, driven by strong performance across Mining Chemicals, Industrial Chemicals, and Crop Nutrition segments. EBITDA surged 65% YoY to ₹845 crores and 139% QoQ, reflecting margin expansion from global supply tightness and strategic pricing. PAT jumped 252% YoY to ₹490 crores with a 26% margin, while operating revenue grew 22% YoY to ₹3,256 crores. The company highlighted capacity expansions in TAN and Nitric Acid projects, with COD expected in Q2 FY27 to boost TAN capacity to 1.0 MMTPA and Nitric Acid to 1.2 MMTPA. Despite monsoon-related demand headwinds in mining, elevated FGAN prices support margins. Net debt reduced to ₹4,719 crores post-₹515 crore capex, aided by robust operational cash flow.

Deepak Fertilizers reported consolidated net profit of [amount not verified] for Q1 FY27, up 101% YoY and 252% QoQ, driven by strong revenue growth across segments. Revenue reached [amount not verified], up 22% YoY, with EBITDA margin at 26%. The company highlighted robust profitability in Mining Chemicals and Pharma/Specialty Chemicals, while Crop Nutrition faced input cost pressures. Capex projects remain on track for Q2 FY27 commissioning. Outlook remains positive for margin expansion and operational resilience.